Biorestorative Therapies Inc (BRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,273 | -5,511 | -4,675 | -7,551 | -14,648 |
| Depreciation Amortization | 1,400 | 1,162 | 1,137 | 1,110 | 3,888 |
| Accounts receivable | 15 | 17 | 13 | 6 | -3 |
| Accounts payable and accrued liabilities | 85 | 145 | 62 | 94 | 97 |
| Other Working Capital | 572 | 1,072 | 976 | 151 | 540 |
| Other Operating Activity | 7,237 | 1,723 | 1,617 | 5,740 | 3,207 |
| Operating Cash Flow | $-1,964 | $-1,392 | $-869 | $-449 | $-6,919 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | N/A | -36 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $-36 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 4,290 | 442 | 442 | 442 | 10,888 |
| Debt Repayment | N/A | N/A | N/A | N/A | -5,708 |
| Common Stock Issued | 10 | 10 | 10 | 10 | 1,659 |
| Other Financing Activity | 727 | 1,115 | 714 | 0 | 0 |
| Financing Cash Flow | $5,027 | $1,567 | $1,166 | $452 | $6,839 |
| Beginning Cash Position | 2 | 2 | 2 | 2 | 118 |
| End Cash Position | 3,065 | 176 | 298 | 5 | 2 |
| Net Cash Flow | $3,063 | $174 | $296 | $3 | $-116 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,964 | -1,392 | -869 | -449 | -6,919 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -36 |
| Free Cash Flow | -1,964 | -1,392 | -869 | -449 | -6,954 |